The evaluation parts will be manufactured at the Amaero facilities in California and Australia. While the financial revenue to be generated from the purchase order is less than Amaero’s $250,000 materiality threshold; still, Amaero is taking this opportunity to showcase its skills to Boeing, and if successful, there are chances for further manufacturing developments.
* Merchant Sales volume of Splitit (ASX: SPT) skyrockets during Black Friday week MSV reached US$15.3 million, up by 216% as compared to the same period in 2019. As a result of this, the year-on-year MSV performance in November increased by 255%. The Average Order Value (AOV) was marked above $1,000.
* Creso (ASX: CPH) To Benefit Over the Landmark Decision from UN Concerning Cannabis Creso Pharma Limited (ASX: CPH), via an ASX announcement on 3 December 2020, shared that the United Nations Commission on Narcotic Drugs has voted to eliminate cannabis from Schedule IV of the 1961 drug convention treaty. Schedule IV substances are counted as the most hazardous and addictive drugs. Cannabis will now be classified under Schedule I, which is the least restrictive drug category.
